Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Cryo Cell International (CCEL) EBT Margin (2016 - 2025)

Historic EBT Margin for Cryo Cell International (CCEL) over the last 16 years, with Q3 2025 value amounting to 15.16%.

  • Cryo Cell International's EBT Margin fell 19500.0% to 15.16% in Q3 2025 from the same period last year, while for Aug 2025 it was 4.57%, marking a year-over-year increase of 433500.0%. This contributed to the annual value of 8.77% for FY2024, which is 514100.0% up from last year.
  • According to the latest figures from Q3 2025, Cryo Cell International's EBT Margin is 15.16%, which was down 19500.0% from 7.25% recorded in Q2 2025.
  • In the past 5 years, Cryo Cell International's EBT Margin registered a high of 22.78% during Q2 2021, and its lowest value of 203.04% during Q4 2023.
  • For the 5-year period, Cryo Cell International's EBT Margin averaged around 1.31%, with its median value being 11.79% (2022).
  • As far as peak fluctuations go, Cryo Cell International's EBT Margin crashed by -2110600bps in 2023, and later skyrocketed by 1925400bps in 2024.
  • Quarter analysis of 5 years shows Cryo Cell International's EBT Margin stood at 17.0% in 2021, then surged by 147bps to 8.02% in 2022, then tumbled by -2632bps to 203.04% in 2023, then skyrocketed by 95bps to 10.5% in 2024, then skyrocketed by 244bps to 15.16% in 2025.
  • Its last three reported values are 15.16% in Q3 2025, 7.25% for Q2 2025, and 6.7% during Q1 2025.